# Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C

> **NCT02120274** · PHASE4 · TERMINATED · sponsor: **Federal University of São Paulo** · enrollment: 85 (actual)

## Conditions studied

- RNA Virus Infections
- Flaviviridae Infections
- Hepatitis C
- Hepatitis C, Chronic

## Interventions

- **DRUG:** Vitamin D
- **DRUG:** Vitamin B 12

## Key facts

- **NCT ID:** NCT02120274
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 85 (ACTUAL)
- **Why stopped:** New Brazilian Guidelines for Viral Hepatitis C and Coinfetions. It does not include the treatment of chronic HCV Metavir \< F3 and abandon the use of interferon.
- **Last updated:** 2016-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120274, "Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02120274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*